Nature Immunology, Published online: 21 August 2026; doi:10.1038/s41590-026-02616-1 In this Review, Hart and colleagues summarize some of the key cellular players and soluble mediators involved in idiopathic pulmonary fibrosis progression, and how distinct types of inflammation jointly regulate disease progression in concert rather than focusing on individual cytokines or immune cells.